| CNS | central nervous system |
| GBM | glioblastoma |
| LGG | low-grade glioma |
| IHC | immunohistochemical |
| GI | genomic instability |
| MIN, MSI | microsatellite instability |
| CIN | chromosomal instability |
| WHO | World Health Organization |
| IDH | isocitrate dehydrogenase |
| ODG | oligodendroglioma |
| HGG | high-grade glioma |
| CAG | circumscribed astrocytic glioma |
| PCA | pilocytic astrocytoma |
| HGAP | high-grade astrocytoma with piloid features |
| PXA | pleomorphic xanthoastrocytoma |
| MN1 | MN1 proto-oncogene, transcriptional regulator |
| DNA | deoxyribonucleic acid |
| CTx | chemotherapy |
| RT | radiotherapy |
| SNI | single nucleotide instability |
| MMR | mismatch repair |
| AP-PCR | arbitrarily primed polymerase chain reaction |
| 5-HTR | 5-hydroxytryptamine (serotonine) receptor |
| AC | adenylyl cyclase |
| ATP | adenosine triphosphate |
| cAMP | 3′-5′-cyclic adenosine monophosphate |
| PKA | protein kinase A |
| EPAC | exchange protein activated by cAMP |
| CREB | CRE-binding protein |
| CREM | cAMP-responsive modulator |
| ATF1 | activating transcription factor 1 |
| Rap1 | Ras-associated protein 1 |
| Rap2 | Ras-associated protein 2 |
| 5-HTR4 | 5-hydroxytryptamine (serotonine) receptor 4 |
| TSG | tumor-suppressor gene |
| PDE | phosphodiesterase |
| PDE4D | cAMP-specific 3′,5′-cyclic phosphodiesterase 4D |
| CA12 F | carbonic anhydrase 12 forward |
| CA 9 R | carbonic anhydrase 9 reverse |
| MDR2 | multi-drug resistance 2 |
| C-MYC1 | cellular myelocytomatosis oncogene 1 |
| MgCl2 | magnesium chloride |
| dNTP | deoxyribonucleoside triphosphate |
| NTC | no-template control |
| FEPE | formalin-fixed paraffin-embedded |
| DAB | diaminobenzidine |
| IRS | immunoreactive score |
| SI | staining intensity |
| PP | percentage of positive cells |
| OR | odds ratio |